M DIDIER GEORGE

Rhumatologue

📍 AMIENS (80)LibéralRPPS 10001835007

✨ Profil synthétique

IA · 23/05/2026

Le Dr Didier George est un rhumatologue exerçant à Amiens en libéral. Ses publications sur PubMed couvrent divers aspects de la rhumatologie, notamment les cas cliniques, l'épidémiologie, les biomarqueurs et la santé mentale. Il a également contribué à des revues et des méta-analyses sur ces sujets.

Expertises présumées

Rhumatologie clinique
Épidémiologie des maladies rhumatismales
Biomarqueurs en rhumatologie
Santé mentale et fatigue chez les patients rhumatismaux
Auto-anticorps et maladies auto-immunes
Fatigue chronique
Systèmes de registres pour les maladies rhumatismales

Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.

✨ Génération du profil synthétique IA en cours…

Lieu de consultation

CABINET DU DR DIDIER GEORGE
4 PLACE DES PROVINCES FRANCAISES, 80000 AMIENS
Activité de soin et de pharmacie

Tarifs & secteur de conventionnement

Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).

📊 Comprendre le remboursement

Prendre rendez-vous & contact

🗓 Trouver sur Doctolib

Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.

Top publications · les plus citées

Five-Year Clinical Outcome and Valve Durability After Transcatheter Aortic Valve Replacement in High-Risk Patients

Circulation · 2018

📚 122 citations🎯 RCR 5.51Top 7% NIH🔓 Open Access📄 PDF gratuit ↗

Lire l'abstract Crossref ↓

Background: The FRANCE-2 registry (French Aortic National Corevalve and Edwards) previously reported good early- and medium-term clinical and echocardiographic efficacy for transcatheter aortic valve replacement. We here report 5-year follow-up results from the registry. Methods: The registry includes all consecutive patients undergoing transcatheter aortic valve replacement for severe aortic stenosis in France. Follow-up is scheduled at 30 days, 6 months, then annually from 1 to 5 years. Clinical events were defined according to the Valve Academic Research Consortium criteria, and hemodynamic structural valve deterioration (SVD) was defined according to the consensus statement by the European Association of Percutaneous Cardiovascular Interventions. Results: Between January 2010 and January 2012, 4201 patients were enrolled in 34 centers. Five-year vital status was available for 95.5% of patients; 88.1% had clinical evaluation or died. Overall, at 5 years, all-cause mortality was 60.8% (n=2478; 95% CI, 59.3% to 62.3%). The majority of cardiovascular events occurred in the first month after valve implantation, and incidence remained low thereafter, at <2% per year up to 5 years, except for heart failure. The rate of heart failure was 14.3% at 1 year, then decreased over time to <5% per year. In cumulative incidence function, the rates of severe SVD and moderate/severe SVD at 5 years were 2.5% and 13.3%, respectively. Mortality did not differ between patients with or without severe SVD (hazard ratio, 0.71; 95% CI, 0.47–1.07; P =0.1). Finally, in the population of patients with severe SVD, 1 patient (1.7%) experienced a stroke, and 8 patients presented ≥1 heart failure event (13.3%). Conclusions: The 5-year follow-up results of the FRANCE-2 registry represent the largest long-term data set available in a high-risk population. In surviving patients, the low rate of clinical events and the low level of SVD after 1 year support the long-term efficacy of transcatheter aortic valve replacement in both types of transcatheter prosthesis featuring in the registry.

Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score

European heart journal · 2018

📚 93 citations🎯 RCR 4.15Top 10% NIH🩺 Clinique

Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents

Scientific reports · 2015

📚 91 citations🎯 RCR 3.75Top 12% NIH🔓 Open Access📄 PDF gratuit ↗

Cookies & analyse de trafic

M DIDIER GEORGE

Pourquoi vous devez consulter ce praticien

Lieu de consultation

Tarifs & secteur de conventionnement

Prendre rendez-vous & contact

Top publications · les plus citées

Publications scientifiques (50) — classées par pathologie

Transversal38

Case report / série3

Épidémiologie & registres2

Revue / méta-analyse2

Revue générale2

Santé mentale / fatigue2

Biomarqueurs / Auto-Ac1

Économie santé1

Essai clinique1

Partager cette fiche